Journal Press India®
A Novel Herbal Formulation of Delstrok® for Patients with Cardiovascular Disorders
Vol 7 , Issue 4 , October - December 2019 | Pages: 1-6 | Research Paper
Received: November 01, 2019 | Revised: November 25, 2019 | Accepted: December 08, 2019 | Published Online: December 15, 2019
Author Details
( * ) denotes Corresponding author
Cases of cardiovascular disease are on the rise and demand for alternative safer methods of treatment is increasing. The study was conducted to determine the efficacy and safety of novel herbal formulation of DELSTROK® tablets in cardiovascular disease. Males and middle aged individuals showed higher risk of cardiovascular diseases. On treatment, majority of the patients showed reduction in weight and body mass index levels, as well as decreased levels of total cholesterol, low-density lipoprotein cholesterol and triglycerides. Most of the patients also showed improvement in high-density lipoprotein cholesterol levels while hs-C-reactive protein levels were lowered in all. Novel herbal formulation of DELSTROK® tablets showed protective potential towards patients suffering from cardiovascular disease. DELSTROK® tablets could be used to treat such patients and improve their quality of life.
Keywords
Body weight; BMI; Cardiovascular disease; Hs-CRP; Lipid profile
- World Health Organization. Preventing chronic disease: a vital investment: WHO global report, 2005.
- World Health Organization. Prevention of Cardiovascular disease: guidelines for assessment and management of cardiovascular risk.
- BJ North, DA Sinclair. The intersection between aging and cardiovascular disease, Circ. Res., 110(8), 2012, 1097-108.
- US Department of Health And Human Services, National Institute of Health, National Heart, Lung, and Blood Institute. Your Guide to Lowering Your Cholesterol with TLC.
- Mayo Clinic Staff, Mayo Foundation for Medical Education and Research (MFMER). Triglycerides: Why do they matter?
- ATME Haque, FBM Yusoff, MHSB Ariffin, MFBA Hamid, SRB Hashim, M Haque. Lipid Profile of the Coronary Heart Disease (CHD) Patients Admitted in a Hospital in Malaysia,”J. Appl. Pharm. Sci., 6, 2016, 137-142.
- MRM Rao, SD Gopal, C-Reactive Protein - A critical Review, Int J Curr Microbiol. Appl Sci, 4(12), 2015, 55-61.
- MD Kumar, MRR Devi, PS Kumar. High Sensitive C - reactive protein – A Risk Marker For Coronary Artery Disease, Journal of Dental and Medical Sciences, 2(3), 2012, 28-32.
- M Shah, N Khalid, H Aslam, Effects of Ginger on LDL-C, Total Cholesterol and Body Weight, Clinical and Medical Biochemistry, 4, 2018, 2.
- W Qidwai, T Ashfaq, Role of Garlic Usage in Cardiovascular Disease Prevention: An Evidence-Based Approach, Evid. Based Complementary Altern. Med, 2013
- FE Sabban, Garlic as an antithrombotic and antiplatelet aggregation agent, Journal of Chinese Clinical Medicine, 4(5), 2009, 288-294
- P Jousilahti, E Vartiainen, J Tuomilehto, P Puska, Sex, Age, Cardiovascular Risk Factors, and Coronary Heart Disease. A Prospective Follow-Up Study of 14 786 Middle-Aged Men and Women in Finland. J. Am. Heart Assoc., 99, 1999, 1165-1172.
- S Pai, CB Shivappa, A Surendra, Anti-obesity and Anti-hyperlipidemic activity of Processed Honey - A Randomised, Open labeled, Controlled Clinical Study, Journal of Research in Traditional Medicine, 4(2), 2018, 40-48.
- A Bhargava, G Tyagi, An experiment on lemon juice supplementation and weight reduction, Asian Journal of Home Science, 5(1), 2010, 66-69.
- N Aslani, MH Entezari, G Askari, Z Maghsoudi, MR Maracy, Effect of Garlic and Lemon Juice Mixture on Lipid Profile and Some Cardiovascular Risk Factors in People 30-60 Years Old with Moderate Hyperlipidaemia: A Randomized Clinical Trial, Int J Prev Med., 7, 2016, 95.
- R Alizadeh-Navaei, F Roozbeh , M Saravi, M Pouramir, F Jalali, AA Moghadamnia, Investigation of the effect of ginger on the lipid levels. A double blind controlled trial, Saudi Med. J., 29(9), 2008, 1280-1284.
- T Arablou, N Aryaeian, M Valizadeh, F Sharifi, A Hosseini, M Djalali, The effect of ginger consumption on glycemic status, lipid profile and some inflammatory markers in patients with type 2 diabetes mellitus, Int. J. Food Sci. Nutr., 65(4), 2014, 515-20.
- MD Mofrad, A Milajerdi, F Koohdani, PJ Surkan, L Azadbakht, Garlic Supplementation Reduces Circulating C-reactive Protein, Tumor Necrosis Factor, and Interleukin-6 in Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials, The Journal of Nutrition, 149(4), 2019, 605–618.
- S Warshafsky, RS Kamer, SL Sivak, Effect of garlic on total serum cholesterol, A meta-analysis, Ann. Intern. Med., 119, 1993, 599-605.
- R Adler, S Lookinland, JA Berry, M Williams, A systematic review of the effectiveness of garlic as an antihyperlipidemic agent, J. Am. Acad. Nurse Pract., 1(5), 2003,120-9.
- N Yaghoobi, N Al-Waili, M Ghayour-Mobarhan, SM Parizadeh, Z Abasalti, Z Yaghoobi, et al, Natural honey and cardiovascular risk factors effects on blood glucose, cholesterol, triacylglycerole, CRP, and body weight compared with sucrose, Scientific World Journal, 8, 2008, 463–469.
- M Mazidi, HK Gao, P Rezaie, GA Ferns, The effect of ginger supplementation on serum C-reactive protein, lipid profile and glycaemia: a systematic review and meta-analysis, Food Nutr. Res., 60, 2016, 32613.
- SK Banerjee, SK Maulik, Effect of garlic on cardiovascular disorders: a review, Nutrition Journal, 1, 2002, 4.
Abstract Views: 1
PDF Views: 98